Loading clinical trials...
Loading clinical trials...
Estimation of Plasma Free and Total Drug Levels of Rifampicin, Isoniazid and Pyrazinamide in Patients on Antituberculosis Therapy and Its Correlation With Development of Drug Induced Hepatotoxicity
Conditions
Locations
1
India
All India Institute of Medical Sciences
New Delhi, India
Start Date
August 1, 2010
Primary Completion Date
June 1, 2012
Completion Date
June 1, 2012
Last Updated
August 31, 2012
NCT06192160
NCT06632444
NCT07024641
NCT02815891
NCT05947890
NCT05989802
Lead Sponsor
All India Institute of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions